Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on AGNC, BLRX, LDK and MCP Issued by the Bedford Report

AGNC, BLRX
Free Research Reports on AGNC, BLRX, LDK and MCP Issued by the Bedford Report
http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=987100&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwire) -- 02/19/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

American Capital Agency Corp. (NASDAQ: AGNC) shares have gained over 12 percent year-to-date. For the full year 2012, AGNC reported a 32% economic return on common equity. The company currently offers investors an annual dividend of $5.00 per share for a dividend yield of approximately 15.4 percent.

Find out more about American Capital Agency including full access to the free equity report at: www.BedfordReport.com/AGNC

Bioline RX Ltd. (NASDAQ: BLRX) shares have gained over 55 percent year-to-date. BioLineRx's current portfolio consists of six clinical stage candidates. The company expects to report results of a Phase II/III trial of their schizophrenia drug during the week of March 18, 2013.

Find out more about Bioline RX including full access to the free equity report at: www.BedfordReport.com/BLRX

LDK Solar Co., Ltd. (NYSE: LDK) shares have gained over 30 percent year-to-date. The company reported net sales for the third quarter of fiscal 2012 grew to $291.5 million, compared to $235.4 million for the second quarter of fiscal 2012.

Find out more about LDK Solar including full access to the free equity report at: www.BedfordReport.com/LDK

Molycorp Inc. (NYSE: MCP) shares of the rare earth miner have fallen over 20 percent year-to-date. The company in a recent news release stated that they anticipate lower than expected revenue and cash flow for 2013. Molycorp is scheduled to release results for the fourth quarter and full year 2012 on Thursday, February 28th.

Find out more about Molycorp including full access to the free equity report at: www.BedfordReport.com/MCP

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact